Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 57 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 7632484

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted
  2. US 7629308

    Methods relating to muscle selective calcineurin interacting protein (MCIP)

    The Board of Regents of the University of Texas System · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted
  3. US 7627938

    Tapered hollow metallic microneedle array assembly and method of making and using the same

    The Board of Regents of the University of Texas System · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted
  4. US 7625563

    Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted
  5. US 7622118

    Cancer treatment methods using selected antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  6. US 7618630

    Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists

    The Board of Regents of the University of Texas System · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  7. US 7619000

    S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer

    The Board of Regents of the University of Texas System · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  8. US 7615223

    Selected immunoconjugates for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted
  9. US 7615208

    Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging

    The Board of Regents of the University of Texas System · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted
  10. US 7611693

    Mechanism-based targeted pancreatic beta cell imaging and therapy

    The Board of Regents of the University of Texas System · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  11. US 7611704

    Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  12. US 7601683

    Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  13. US 7601731

    Antimicrobial flush solutions

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  14. US 7601490

    Development of influenza A antivirals

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  15. US 7582281

    Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  16. US 7579014

    Mesoporous compositions for use in drug delivery

    The Board of Regents of the University of Texas System · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted
  17. US 7576194

    UspA2 nucleic acid of moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted
  18. US 7572442

    Selected antibody compositions for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted
  19. US 7572448

    Combined cancer treatment methods using selected antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted
  20. US 7569683

    UspA2 nucleic acid of Moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted
  21. US 7563446

    Methods and compositions for inducing autoimmunity in the treatment of cancers

    The Board of Regents of the University of Texas System · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted
  22. US 7556942

    Tumor suppressor designated Hippo

    The Board of Regents of the University of Texas System · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted
  23. US 7550617

    Compositions and methods for the treatment of renal and cardiovascular disease

    The Board of Regents of the University of Texas System · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted
  24. US 7550141

    Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted